Informations générales (source: ClinicalTrials.gov)
Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic
Observational
Gustave Roussy, Cancer Campus, Grand Paris (Voir sur ClinicalTrials)
janvier 2018
décembre 2024
15 septembre 2025
Multicentric prospective study with collection of biological samples as part of type II
research
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT GUSTAVE ROUSSY | Laurence ZITVOGEL | 29/04/2024 15:04:23 | Contacter | ||
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| HOPITAL FOCH | lundi 15 septembre 2025 | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre hospitalier du Pays d'Aix - 13616 - Aix-en-Provence - France | Stéphanie MARTINEZ, MD | Contact (sur clinicalTrials) | |||
| Centre hospitalier TOULON - Sainte-Musse - 83056 - Toulon - France | Clarisse AUDIGIER-VALETTE, MD | Contact (sur clinicalTrials) | |||
| Centre Léon Bérard - 69008 - Lyon - France | Armelle VINCENEUX, MD | Contact (sur clinicalTrials) | |||
| Centre Pierre Curie - 62660 - Beuvry - France | Jean-Briac PREVOST, MD | Contact (sur clinicalTrials) | |||
| CHRU Lille - Hôpital Calmette - 59037 - Lille - France | Arnaud SCHERPEREEL, MD, PhD | Contact (sur clinicalTrials) | |||
| Clinique du Flandre - 59210 - Coudekerque-Branche - France | Jean-Philippe WAGNER, MD | Contact (sur clinicalTrials) | |||
| Hôpital St Louis - 75010 - Paris - France | Safae TERRISSE, MD, PhD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Patient with cancer who will start treatment anticancer (see cohorts).
- Patient information and signature of the consent form before any specific procedure
for the study. The patient must be able and must be inclined to cooperate in the
study procedures.
- Patient affiliated to a social security scheme or beneficiary of a similar scheme.
- Patient with cancer who will start treatment anticancer (see cohorts).
- Patient information and signature of the consent form before any specific procedure
for the study. The patient must be able and must be inclined to cooperate in the
study procedures.
- Patient affiliated to a social security scheme or beneficiary of a similar scheme.
- Pregnant or lactating woman
- Patient under guardianship or curatorship or deprived of liberty by a decision
judicial or administrative or patient unable to give his consent.